<?xml version="1.0"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">

	<channel>
<atom:link href="http://www.ptca.org/rss_news.xml" rel="self" type="application/rss+xml" />

	
<title>Angioplasty.Org News</title>
<link>http://www.ptca.org/</link> 
<description>Breaking news about stents, angioplasty, the medical device industry, balloons, diagnostic imaging, interventional cardiology, stent thrombosis, restenosis from Angioplasty.Org</description> 
<language>en-us</language> 
<copyright>copyright  2006-23 Venture Digital LLC</copyright> 
<lastBuildDate>07 Feb 2023 17:03:00 PDT</lastBuildDate>
<image>
<title>Angioplasty.Org News</title>
<url>http://www.ptca.org/images/nav/angio_logo1.gif</url>
<link>http://www.ptca.org/</link> 
</image>
		
		<item>
	   <title>Recor's Paradise Renal Denervation System
Gets FDA Approval</title>
	   <link>http://www.ptca.org/news/2023/1113_RECOR_RDN.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/1113_RECOR_RDN.html</guid>
	   <description>The Paradise RDN system had been approved for the CE Mark in Europe over a decade ago, as have several other systems from Medtronic, et al, but this is the first system that has received approval to be marketed in the U.S.</description>	     
	   <pubDate>Mon, 13 Nov 2023 19:12:00 PST</pubDate>
</item>


		
<item>
	   <title>New Shockwave IVL Catheter to Debut at #TCT2023</title>
	   <link>http://www.ptca.org/news/2023/1021_SHOCKWAVE_C2+.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/1021_SHOCKWAVE_C2+.html</guid>
	   <description>Shockwave Medical, will be introducing their latest iteration of the intravascular Lithotripsy Catheter, the C2+, just approved by the U.S. FDA. The C2+ provides 50% more pulses and, according to Dr. Richard Shlofmitz of St. Francis Hospital in Roslyn, NY,"will be an added benefit of IVL for optimally treating complex calcium, including more diffuse disease, as well as nodular and thick, eccentric calcium."</description>	     
	   <pubDate>Sat, 21 Oct 2023 19:28:00 PDT</pubDate>
</item>


		
<item>
	   <title>Medtronic's Evolut FX TAVI System Gets CE Mark</title>
	   <link>http://www.ptca.org/news/2023/1012_MEDTRONIC_EVOLUT_FX.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/1012_MEDTRONIC_EVOLUT_FX.html</guid>
	   <description>Medtronic today announced that its latest iteration of the Evolut TAVI/TAVR system, the Evolut™ FX, has received the CE (Conformité Européenne) Mark. Although medical devices often are approved in Europe prior to US approval, the Evolut FX did the opposite: it garnered US FDA approval two years ago. Today's announcement means that this newest and most advanced transcatheter platform for treating severe aortic stenosis will now be available in Europe and beyond. </description>	     
	   <pubDate>Thu, 12 Oct 2023 19:37 PDT</pubDate>
</item>

		
		
<item>
	   <title>"It's Time!" Say the Major Cardiology Organizations Regarding a Change to the Process of Physician Certification</title>
	   <link>http://www.ptca.org/news/2023/0921_CVBOARD.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/0921_CVBOARD.html</guid>
	   <description>They no longer wish to be subject to certification by the American Board of Internal Medicine (ABIM) and are addressing the long-standing complaints of a wide range of cardiologists who claim that the certification requirements of ABIM are not in any way related to their day-to-day practice, are needlessly time-consuming, and are expensive.</description>	     
	   <pubDate>Thu, 21 Sep 2023 19:10:00 PDT</pubDate>
</item>


		
		<item>
	   <title>Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device</title>
	   <link>http://www.ptca.org/news/2023/0906_BOSTONSCIENTIFIC_WATCHMAN.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/0906_BOSTONSCIENTIFIC_WATCHMAN.html</guid>
	   <description>Designed to further advance the procedural performance and safety of the WATCHMAN technology, which is indicated to reduce stroke risk in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy, the device now features a polymer coating, visualization markers and a broader size matrix to treat a wider range of patients. </description>	     
	   <pubDate>Thu, 07 Sep 2023 18:40:00 PDT</pubDate>
</item>


		
	<item>
	   <title>Interview with Dr. B. Clay Sizemore About Calcium Modification with IVL in Hospitals That Do Not Have Surgical Backup</title>
	   <link>http://www.ptca.org/stentcenter/sizemore_interview.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/stentcenter/sizemore_interview.html</guid>
	   <description>In this interview, Dr. Sizemore discusses how intravascular lithotripsy (IVL) has been a game-changer for patients with significant calcified lesions -- that instead of having to transport them to a distant hospital, he is able to safely and efficaciously treat them in Thomasville, Georgia.</description>	     
	   <pubDate>Fri, 11 Aug 2023 19:47:00 PDT</pubDate>
</item>


		<item>
	   <title>Centers For Medicare and Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy</title>
	   <link>http://www.ptca.org/news/2023/0802_SHOCKWAVE.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/0802_SHOCKWAVE.html</guid>
	   <description>Shockwave Medical, Inc. (NASDAQ: SWAV) announced today that as part of the Fiscal Year 2024 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule, the Centers for Medicare and Medicaid Services (CMS) has created new Medicare Severity Diagnosis Related Group (MS-DRG) codes and payments for coronary Intravascular Lithotripsy (IVL) in the hospital inpatient setting.</description>	     
	   <pubDate>Tue, 08 Aug 2023 20:30:00 PDT</pubDate>
</item>


		
		
	<item>
	   <title>Medtronic Receives FDA Approval For Its Next Generation Micra Leadless Pacing Systems</title>
	   <link>http://www.ptca.org/news/2023/0501_MEDTRONIC_MICRA.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/0501_MEDTRONIC_MICRA.html</guid>
	   <description>Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™ AV2 and Micra™ VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. Micra AV2 and Micra VR2, the world's smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless pacing such as reduced complications compared to traditional pacemakers.</description>	     
	   <pubDate>Tue, 09 May 2023 15:25:00 PDT</pubDate>
</item>
		
		<item>
	   <title>SCCT Honors Dr. Martha Gulati with 2023 Arthur S. Agatston Award</title>
	   <link>http://ptca.org/news/2023/0503_SCCT_GULATI.html</link>
	   <guid isPermaLink="true">http://ptca.org/news/2023/0503_SCCT_GULATI.html</guid>
	   <description>The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that Martha Gulati, MD, FACC, FAHA, FASPC, FESC has been named the recipient of the 2023 Arthur S. Agatston Cardiovascular Disease Prevention Award for her extensive contributions to the study of women and cardiac diseases and to efforts to improve women’s healthcare.</description>	     
	   <pubDate>Wed, 03 May 2023 17:15:00 PDT</pubDate>
</item>



		
		
		<item>
	   <title>Three-Year Results of Medtronic's Evolut TAVR Compared to Surgery in Low Risk Patients
Presented at ACC</title>
	   <link>http://www.ptca.org/news/2023/0305_MEDTRONIC_EVOLUT.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/0305_MEDTRONIC_EVOLUT.html</guid>
	   <description>The 3-year comparative data for Medtronic's CoreValve/Evolut TAVR vs. SAVR for low risk patients that were presented at today's late-breaking clinical trials session were much needed and the results showed that this device compared favorably with surgery and, in some respects, was superior.</description>	     
	   <pubDate>Sun, 05 Mar 2023 18:58:00 PDT</pubDate>
</item>


		
<item>
	   <title>Medtronic CoreValve/Evolut™ Demonstrates Best Durability</title>
	   <link>http://www.ptca.org/news/2023/0227_MEDTRONIC_EVOLUT.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/0227_MEDTRONIC_EVOLUT.html</guid>
	   <description>Medtronic today announced five-year bioprosthetic valve dysfunction (BVD) data for the CoreValve/Evolut™ platform, the first and only transcatheter aortic valve replacement (TAVR) platform to show significantly better valve performance and durability compared to surgical aortic valve replacement (SAVR) at five years. Data, presented by Dr. Steven Yakubov, in a late-breaking clinical trial session at the 2023 annual meeting of Cardiovascular Research Technologies (CRT 2023), build upon the excellent results of the structural valve deterioration (SVD) analysis recently published in JAMA Cardiology.</description>	     
	   <pubDate>Mon, 27 Feb 2023 13:07:00 PDT</pubDate>
</item>

<item>
	   <title>Medtronic Continues to Make Significant Advances as an Inclusion, Diversity and Equity Leader</title>
	   <link>http://www.ptca.org/news/2023/0201_MEDTRONIC_DIVERSITY.html</link>
	   <guid isPermaLink="true">http://www.ptca.org/news/2023/0201_MEDTRONIC_DIVERSITY.html</guid>
	   <description>Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that it joins 483 other global companies as a member of the 2023 Bloomberg Gender-Equality Index (GEI), a modified market capitalization-weighted index developed to gauge the performance of public companies dedicated to reporting gender-related data. </description>	     
	   <pubDate>Tue, 07 Feb 2023 18:00:00 PDT</pubDate>
</item>


		
<item>
	   <title>Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status</title>
	   <link>http://ptca.org/news/2023/0131_SHOCKWAVE.html</link>
	   <guid isPermaLink="true">http://ptca.org/news/2023/0131_SHOCKWAVE.html</guid>
	   <description>Shockwave Medical, Inc. announced that coronary IVL was included in a treatment guidance document published by the Society of Cardiovascular Angiography and Intervention (SCAI) as a potential therapeutic option in all U.S. catheterization labs. - including facilities without on-site surgical backup.
</description>	     
	   <pubDate>Tue, 31 Jan 2023 16:15:00 PDT</pubDate>
</item>


	</channel>
</rss>